Stocks were mostly higher Monday as President Donald Trump was scheduled to meet with Ukraine President Volodymyr Zelensky ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

It has been a rough year for healthcare stocks on the S&P 500, but Warren Buffett’s move into UnitedHealth Group Inc. could ...

Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from ...

A new report shows how much prices for the same medical service can vary at different hospitals and surgery centers.

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world, and his annual ...

UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided ...

Columbia Threadneedle’s Disciplined Core Fund returned 9.54% in Q2 2025, led by AI-fueled tech picks. Discover how stock ...